Skip to main content
OpenTrials
Completed

NCT Number: NCT03810261

Challenges in Achieving Adequate Vitamin D Status in the Adult Population/ Part 2

The efficiency of different vitamin D formulations in treating suboptimal vitamin D status in adult population will be determined. It will provide insights into the influence of formulation on vitamin D absorption.

A randomised controlled intervention trial will be conducted on at least 72 subjects (18-65 years) with suboptimal Vitamin D status. Subjects will be selected from a pool of subjects in Part 1 of the study, after completion of winter sampling.

Study subjects will be randomised into four study groups (at least 18 subjects per study group). Three different treatments will be compared with a control group, which will not receive any supplemental Vitamin D. The three tested Vitamin D preparations in the treatment groups will be (A) oil-based VALENS vitamin D; (B) water-based VALENS vitamin D; and (C) Vitamin D capsules with starch-adsorbed vitamin D (powder). All these products are commercially available. Prior to study, actual level of vitamin D will be determined using appropriate analytical method. The treatment will be with 1000 IU Vitamin D per day, for two months, in all three groups. Second serum vitamin D level will be determined on last day of the treatment, and compared with pre-treatment vitamin D level.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Vitamin D Deficiency Avitaminosis Deficiency Diseases Malnutrition Nutrition Disorders Nutritional and Metabolic Diseases

Age range

18 year–65 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Nutrition Institute, Ljubljana

Ljubljana, 1000, Slovenia

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • vitamin D suboptimal status
  • Signed Informed consent form (ICF),
  • Caucasian race
  • Age between 18 and 65 years at the time of the signature of Informed consent form (ICF),
  • Willingness to avoid a consumption of any food supplements containing Vitamin D during the study, except the ones prescribed by the study researchers, and to avoid use of solarium or other artificial UVB sources
  • Willingness to follow all study procedures

Exclusion criteria

  • Pregnancy or breastfeeding,
  • Known or suspected allergy to any ingredient of the tested products in Part 2,
  • Pronounced avoidance of sunshine (eg reporting of allergy to the sun)
  • Use of food supplements containing Vitamin D or fish oil or omega 3 fatty acids in last three months prior to inclusion,
  • Special dietary habits used by a small part of the population (veganism, low-carb high-fat (LCHF) diet, caloric restriction diet, note: vegetarians are not excluded)
  • Diets prescribed by the medical profession
  • Disorders of the kidneys, thyroid, digestive tract, osteoporosis and other bone diseases, skin diseases
  • Other diseases and conditions that affect the absorption and synthesis of vitamin D
  • Exposure to stronger sunlight in the last three months prior to engaging in a survey (travel to countries with stronger sunshine, use of solarium),
  • The consumption of margarine or plant substitutes for milk / milk products several times a day, as these foods are most often enriched with vitamin D,
  • Visiting the solarium in the last three months before joining the survey,
  • Mental incapacity that precludes adequate understanding or cooperation.

Treatment and study plan

Oil-based vitamin D

Dietary Supplement

Participants will receive oil-based VALENS vitamin D, 1000 IU/day for 8 weeks.

Water-based vitamin D

Dietary Supplement

Participants will receive water-based VALENS vitamin D, 1000 IU/day for 8 weeks.

Vitamin D capsules

Dietary Supplement

Participants will receive vitamin D capsules with starch-adsorbed vitamin D (powder), 1000 IU/day for 8 weeks.

Primary outcomes

  1. Change in vitamin D serum concentration after 8 weeks of supplementation

    Time frame: 8 weeks

Sponsors and collaborators

Lead sponsor

Institute of Nutrition, Slovenia (Nutris)

Other

Collaborators

  • Slovenian Research Agency
  • VIST - Faculty of Applied Sciences
  • Valens Int. d.o.o., Slovenija

Registry information

Official study title

Challenges in Achieving Adequate Vitamin D Status in the Adult Population - Part 2

Acronym: VITAD/2

Important dates

Study start
2019
Primary completion
2019
Study completion
2019
First posted
Jan 18, 2019
Registry last updated
Jun 22, 2021

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.